The bio/pharmaceutical analytical and bioanalytical contract solutions provider recently announced the opening of the new facility in Wiesbaden, Germany, which will offer extractables and leachables testing to the industry.
The offerings were previously available at the company’s Taunusstein, Germany-based laboratory, approximately 20 kilometers from the new site. However, as Dr. Sheida Hoenlinger, Director, Life Sciences Germany at SGS told us, “market demand” has necessitated the investment to “enhance capabilities.”
The new facility will span 500 square meters and will accommodate equipment and instruments transferred from Taunusstein as well as newly acquired pieces, which have been qualified and validated in the new laboratory.
Hoenlinger explained the new facility will feature “enhanced capabilities for extractable studies and investment in equipment for high level impurity profiling which is where we are seeing growing demand.”
Hoenlinger told us the company has specifically been seeing an increasing demand for “high quality and short turnaround times.”
“We anticipate growing client demand and needs in terms of capacity, quality and delivery time for their extractable and impurity profiling studies,” she added.
According to the company, all ongoing projects have been transferred to the Wiesbaden facility successfully. The recently freed space at Taunusstein will also allow SGS to expand its quality control release testing capabilities at that facility.